HPV Infection & Anal Cancer Risk
In recent years, it has become clear that HPV (Human Papillomavirus) infection is a major risk factor for the development of anal cancer, particularly in:
- HIV-positive individuals
- Immunosuppressed patients
- Men who have sex with men (MSM)
These groups are especially vulnerable to precancerous lesions, which can progress to cancer if not treated early.
The Role of High-Resolution Anoscopy (HRA)
High-Resolution Anoscopy (HRA) allows for early detection and treatment, significantly reducing the risk of cancer and improving outcomes.
Based on the ANCHOR study findings, early intervention with HRA:
- Prevents lesion progression
- Improves prognosis
- Lowers morbidity in high-risk groups
New Techniques and Therapies
Modern proctology benefits from advanced, minimally invasive techniques that reduce surgical trauma and recovery time.
Hemorrhoid Treatments
- Laser Therapy (LHP): Shrinks hemorrhoids without removing tissue. Quick recovery, minimal pain.
- HAL-RAR: Ligation of hemorrhoidal arteries and lifting of the rectal canal. Long-term relief with low discomfort.
Fistula Treatments
- FiLaC: Internal laser closure of fistula tract. Minimal tissue damage.
- LIFT: Ligation at the fistula base. Preserves sphincter function and avoids incontinence.
- Mucosal Advancement Flap: Covers fistula with healthy tissue. Effective in complex or high fistulas.
Pilonidal Cyst Treatments
- VAAFT: Video-assisted endoscopic cleaning of pilonidal sinus. Less pain, faster healing.
- EPSiT: Endoscopic cleaning and wall rejuvenation of the cyst to promote healing.
HPV and Anal Cancer Prevention – A Clinical Priority
HPV remains a critical factor in anal cancer development, especially in vulnerable populations. HRA allows:
- Timely treatment of precancerous lesions
- Reduced cancer risk
- Improved long-term prognosis
HRA is a key tool in early detection and intervention, especially for high-risk individuals.
